Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
9.85
-0.08 (-0.81%)
Aug 13, 2026, 11:46 AM EDT - Market open

Burning Rock Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
104212739523110,017
Market Cap Growth
39.03%191.77%-23.75%-58.75%-97.69%313.84%
Enterprise Value
46.59149.738.5910.12107.069,795
Last Close Price
9.8520.156.759.3022.5095.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.402.751.031.252.83125.36
PB Ratio
1.402.770.910.881.3834.50
P/TBV Ratio
0.200.400.130.120.200.54

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.641.940.120.131.31122.59

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.060.050.050.000.010.03
Net Debt / Equity Ratio
-0.76-0.81-0.80-0.78-0.74-0.76
Net Debt / EBITDA Ratio
6.7513.161.531.131.001.88
Net Debt / FCF Ratio
11.5512.924.792.281.622.05
Asset Turnover
0.640.630.540.410.290.21
Inventory Turnover
2.552.462.331.751.451.50
Quick Ratio
2.712.672.572.902.574.38
Current Ratio
3.052.992.923.363.064.89
Return on Equity (ROE)
-11.28%-9.92%-51.38%-67.85%-64.67%-37.35%
Return on Assets (ROA)
-7.08%-6.24%-36.50%-50.76%-50.61%-32.22%
Return on Invested Capital (ROIC)
-51.44%-49.94%-251.94%-284.19%-264.22%-245.97%
Return on Capital Employed (ROCE)
-10.34%-9.20%-51.24%-68.55%-63.61%-36.83%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-1.44%2.26%-5.05%0.20%2.35%-0.31%
Total Shareholder Return
-1.44%2.26%-5.05%0.20%2.35%-0.31%
SEC Filings: 10-K · 10-Q